Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016
10 . 10 . 2016

Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016

At the 30th European Association for Cardio-Thoracic Surgery (EACTS) annual meeting, Xeltis announced the successful start of clinical trials for its bioabsorbable pulmonary valve and two-year clinical data showing positive functionality of its technology. Moreover, a panel of global cardiology experts was joined by Nobel prize laureate, Professor Jean-Marie Lehn, at the well-received “Reinventing the heart valve” symposium. Watch video highlights.

For more on the Xeltis technology, view the ETR video here

Go back